nodes	percent_of_prediction	percent_of_DWPC	metapath
Tetrabenazine—CBR1—Doxorubicin—pancreatic cancer	0.672	0.828	CbGbCtD
Tetrabenazine—CYP2D6—Tamoxifen—pancreatic cancer	0.0617	0.076	CbGbCtD
Tetrabenazine—CYP2D6—Erlotinib—pancreatic cancer	0.0525	0.0646	CbGbCtD
Tetrabenazine—CYP2D6—Doxorubicin—pancreatic cancer	0.0259	0.0319	CbGbCtD
Tetrabenazine—CBR1—Azacitidine—Gemcitabine—pancreatic cancer	0.0048	1	CbGdCrCtD
Tetrabenazine—CBR1—NRF2 pathway—FGF13—pancreatic cancer	0.00198	0.115	CbGpPWpGaD
Tetrabenazine—SLC18A2—Dopaminergic Neurogenesis—GLI1—pancreatic cancer	0.00114	0.066	CbGpPWpGaD
Tetrabenazine—CBR1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—pancreatic cancer	0.00113	0.0657	CbGpPWpGaD
Tetrabenazine—Ataxia—Fluorouracil—pancreatic cancer	0.000985	0.00596	CcSEcCtD
Tetrabenazine—Bradycardia—Sunitinib—pancreatic cancer	0.000936	0.00566	CcSEcCtD
Tetrabenazine—Mental disorder—Erlotinib—pancreatic cancer	0.00093	0.00562	CcSEcCtD
Tetrabenazine—Urinary tract disorder—Sunitinib—pancreatic cancer	0.000908	0.00549	CcSEcCtD
Tetrabenazine—Dysphagia—Fluorouracil—pancreatic cancer	0.000906	0.00548	CcSEcCtD
Tetrabenazine—Urethral disorder—Sunitinib—pancreatic cancer	0.000901	0.00545	CcSEcCtD
Tetrabenazine—Upper respiratory tract infection—Irinotecan—pancreatic cancer	0.000879	0.00531	CcSEcCtD
Tetrabenazine—Eye disorder—Sunitinib—pancreatic cancer	0.000859	0.00519	CcSEcCtD
Tetrabenazine—Cardiac disorder—Sunitinib—pancreatic cancer	0.000853	0.00516	CcSEcCtD
Tetrabenazine—Upper respiratory tract infection—Fluorouracil—pancreatic cancer	0.000842	0.00509	CcSEcCtD
Tetrabenazine—Blood disorder—Epirubicin—pancreatic cancer	0.000842	0.00509	CcSEcCtD
Tetrabenazine—Leukopenia—Tamoxifen—pancreatic cancer	0.000836	0.00505	CcSEcCtD
Tetrabenazine—Angiopathy—Sunitinib—pancreatic cancer	0.000834	0.00504	CcSEcCtD
Tetrabenazine—SLC18A2—Dopaminergic Neurogenesis—SHH—pancreatic cancer	0.000824	0.0477	CbGpPWpGaD
Tetrabenazine—Sweating—Irinotecan—pancreatic cancer	0.000808	0.00489	CcSEcCtD
Tetrabenazine—Mental disorder—Sunitinib—pancreatic cancer	0.000805	0.00487	CcSEcCtD
Tetrabenazine—Anxiety—Tamoxifen—pancreatic cancer	0.000792	0.00479	CcSEcCtD
Tetrabenazine—Sweating—Gemcitabine—pancreatic cancer	0.000788	0.00476	CcSEcCtD
Tetrabenazine—Anxiety—Erlotinib—pancreatic cancer	0.000784	0.00474	CcSEcCtD
Tetrabenazine—Unspecified disorder of skin and subcutaneous tissue—Erlotinib—pancreatic cancer	0.000781	0.00472	CcSEcCtD
Tetrabenazine—Blood disorder—Doxorubicin—pancreatic cancer	0.000779	0.00471	CcSEcCtD
Tetrabenazine—Dry mouth—Tamoxifen—pancreatic cancer	0.000778	0.0047	CcSEcCtD
Tetrabenazine—Bradycardia—Irinotecan—pancreatic cancer	0.000771	0.00466	CcSEcCtD
Tetrabenazine—Dysarthria—Epirubicin—pancreatic cancer	0.000743	0.00449	CcSEcCtD
Tetrabenazine—Nervous system disorder—Erlotinib—pancreatic cancer	0.00074	0.00447	CcSEcCtD
Tetrabenazine—Hyperhidrosis—Tamoxifen—pancreatic cancer	0.000737	0.00445	CcSEcCtD
Tetrabenazine—Skin disorder—Erlotinib—pancreatic cancer	0.000733	0.00443	CcSEcCtD
Tetrabenazine—Urinary tract disorder—Gemcitabine—pancreatic cancer	0.000728	0.0044	CcSEcCtD
Tetrabenazine—Urethral disorder—Gemcitabine—pancreatic cancer	0.000723	0.00437	CcSEcCtD
Tetrabenazine—Gait disturbance—Epirubicin—pancreatic cancer	0.00072	0.00435	CcSEcCtD
Tetrabenazine—Leukopenia—Sunitinib—pancreatic cancer	0.000716	0.00433	CcSEcCtD
Tetrabenazine—Ataxia—Docetaxel—pancreatic cancer	0.000711	0.0043	CcSEcCtD
Tetrabenazine—Cardiac disorder—Irinotecan—pancreatic cancer	0.000703	0.00425	CcSEcCtD
Tetrabenazine—Abdominal pain upper—Docetaxel—pancreatic cancer	0.000691	0.00418	CcSEcCtD
Tetrabenazine—Orthostatic hypotension—Docetaxel—pancreatic cancer	0.000691	0.00418	CcSEcCtD
Tetrabenazine—Insomnia—Tamoxifen—pancreatic cancer	0.000689	0.00417	CcSEcCtD
Tetrabenazine—Dysarthria—Doxorubicin—pancreatic cancer	0.000688	0.00416	CcSEcCtD
Tetrabenazine—Angiopathy—Irinotecan—pancreatic cancer	0.000687	0.00415	CcSEcCtD
Tetrabenazine—Cardiac disorder—Gemcitabine—pancreatic cancer	0.000684	0.00414	CcSEcCtD
Tetrabenazine—Breast disorder—Docetaxel—pancreatic cancer	0.000684	0.00413	CcSEcCtD
Tetrabenazine—Insomnia—Erlotinib—pancreatic cancer	0.000682	0.00412	CcSEcCtD
Tetrabenazine—Dyspnoea—Tamoxifen—pancreatic cancer	0.00068	0.00411	CcSEcCtD
Tetrabenazine—Unspecified disorder of skin and subcutaneous tissue—Sunitinib—pancreatic cancer	0.000676	0.00409	CcSEcCtD
Tetrabenazine—Dyspnoea—Erlotinib—pancreatic cancer	0.000672	0.00406	CcSEcCtD
Tetrabenazine—Angiopathy—Gemcitabine—pancreatic cancer	0.000669	0.00404	CcSEcCtD
Tetrabenazine—Gait disturbance—Doxorubicin—pancreatic cancer	0.000666	0.00403	CcSEcCtD
Tetrabenazine—Dry mouth—Sunitinib—pancreatic cancer	0.000666	0.00403	CcSEcCtD
Tetrabenazine—Decreased appetite—Tamoxifen—pancreatic cancer	0.000663	0.00401	CcSEcCtD
Tetrabenazine—Fatigue—Tamoxifen—pancreatic cancer	0.000657	0.00397	CcSEcCtD
Tetrabenazine—Decreased appetite—Erlotinib—pancreatic cancer	0.000656	0.00396	CcSEcCtD
Tetrabenazine—Dysphagia—Docetaxel—pancreatic cancer	0.000654	0.00395	CcSEcCtD
Tetrabenazine—Constipation—Tamoxifen—pancreatic cancer	0.000652	0.00394	CcSEcCtD
Tetrabenazine—Fatigue—Erlotinib—pancreatic cancer	0.00065	0.00393	CcSEcCtD
Tetrabenazine—Constipation—Erlotinib—pancreatic cancer	0.000645	0.0039	CcSEcCtD
Tetrabenazine—Nervous system disorder—Sunitinib—pancreatic cancer	0.00064	0.00387	CcSEcCtD
Tetrabenazine—Ecchymosis—Epirubicin—pancreatic cancer	0.000635	0.00384	CcSEcCtD
Tetrabenazine—Skin disorder—Sunitinib—pancreatic cancer	0.000634	0.00383	CcSEcCtD
Tetrabenazine—Body temperature increased—Erlotinib—pancreatic cancer	0.000596	0.0036	CcSEcCtD
Tetrabenazine—Insomnia—Sunitinib—pancreatic cancer	0.000591	0.00357	CcSEcCtD
Tetrabenazine—Leukopenia—Irinotecan—pancreatic cancer	0.00059	0.00357	CcSEcCtD
Tetrabenazine—Ecchymosis—Doxorubicin—pancreatic cancer	0.000588	0.00355	CcSEcCtD
Tetrabenazine—Dyspnoea—Sunitinib—pancreatic cancer	0.000582	0.00352	CcSEcCtD
Tetrabenazine—Leukopenia—Gemcitabine—pancreatic cancer	0.000575	0.00347	CcSEcCtD
Tetrabenazine—Decreased appetite—Sunitinib—pancreatic cancer	0.000568	0.00343	CcSEcCtD
Tetrabenazine—Leukopenia—Fluorouracil—pancreatic cancer	0.000565	0.00342	CcSEcCtD
Tetrabenazine—Fatigue—Sunitinib—pancreatic cancer	0.000563	0.0034	CcSEcCtD
Tetrabenazine—Constipation—Sunitinib—pancreatic cancer	0.000558	0.00338	CcSEcCtD
Tetrabenazine—CBR1—NRF2 pathway—NFE2L2—pancreatic cancer	0.000556	0.0322	CbGpPWpGaD
Tetrabenazine—Asthenia—Tamoxifen—pancreatic cancer	0.000547	0.00331	CcSEcCtD
Tetrabenazine—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—pancreatic cancer	0.000543	0.00328	CcSEcCtD
Tetrabenazine—Confusional state—Irinotecan—pancreatic cancer	0.000542	0.00328	CcSEcCtD
Tetrabenazine—Asthenia—Erlotinib—pancreatic cancer	0.000541	0.00327	CcSEcCtD
Tetrabenazine—CBR1—NRF2 pathway—TGFA—pancreatic cancer	0.000531	0.0307	CbGpPWpGaD
Tetrabenazine—Nervous system disorder—Irinotecan—pancreatic cancer	0.000527	0.00319	CcSEcCtD
Tetrabenazine—Diarrhoea—Tamoxifen—pancreatic cancer	0.000522	0.00315	CcSEcCtD
Tetrabenazine—Hyperhidrosis—Irinotecan—pancreatic cancer	0.00052	0.00314	CcSEcCtD
Tetrabenazine—Confusional state—Fluorouracil—pancreatic cancer	0.000519	0.00314	CcSEcCtD
Tetrabenazine—CBR1—NRF2 pathway—SLC2A2—pancreatic cancer	0.000519	0.0301	CbGpPWpGaD
Tetrabenazine—Urinary tract disorder—Docetaxel—pancreatic cancer	0.000517	0.00312	CcSEcCtD
Tetrabenazine—Body temperature increased—Sunitinib—pancreatic cancer	0.000516	0.00312	CcSEcCtD
Tetrabenazine—Diarrhoea—Erlotinib—pancreatic cancer	0.000516	0.00312	CcSEcCtD
Tetrabenazine—Nervous system disorder—Gemcitabine—pancreatic cancer	0.000514	0.00311	CcSEcCtD
Tetrabenazine—Urethral disorder—Docetaxel—pancreatic cancer	0.000513	0.0031	CcSEcCtD
Tetrabenazine—Osteoarthritis—Epirubicin—pancreatic cancer	0.00051	0.00308	CcSEcCtD
Tetrabenazine—Skin disorder—Gemcitabine—pancreatic cancer	0.000509	0.00308	CcSEcCtD
Tetrabenazine—Hyperhidrosis—Gemcitabine—pancreatic cancer	0.000506	0.00306	CcSEcCtD
Tetrabenazine—Nervous system disorder—Fluorouracil—pancreatic cancer	0.000505	0.00305	CcSEcCtD
Tetrabenazine—Dizziness—Tamoxifen—pancreatic cancer	0.000504	0.00305	CcSEcCtD
Tetrabenazine—Hypotension—Irinotecan—pancreatic cancer	0.000503	0.00304	CcSEcCtD
Tetrabenazine—Dizziness—Erlotinib—pancreatic cancer	0.000499	0.00301	CcSEcCtD
Tetrabenazine—Hypotension—Gemcitabine—pancreatic cancer	0.00049	0.00296	CcSEcCtD
Tetrabenazine—Eye disorder—Docetaxel—pancreatic cancer	0.000489	0.00296	CcSEcCtD
Tetrabenazine—Insomnia—Irinotecan—pancreatic cancer	0.000486	0.00294	CcSEcCtD
Tetrabenazine—Cardiac disorder—Docetaxel—pancreatic cancer	0.000486	0.00294	CcSEcCtD
Tetrabenazine—Vomiting—Tamoxifen—pancreatic cancer	0.000485	0.00293	CcSEcCtD
Tetrabenazine—Hypotension—Fluorouracil—pancreatic cancer	0.000481	0.00291	CcSEcCtD
Tetrabenazine—Ataxia—Epirubicin—pancreatic cancer	0.00048	0.0029	CcSEcCtD
Tetrabenazine—Vomiting—Erlotinib—pancreatic cancer	0.00048	0.0029	CcSEcCtD
Tetrabenazine—Dyspnoea—Irinotecan—pancreatic cancer	0.000479	0.0029	CcSEcCtD
Tetrabenazine—Somnolence—Irinotecan—pancreatic cancer	0.000478	0.00289	CcSEcCtD
Tetrabenazine—Headache—Tamoxifen—pancreatic cancer	0.000478	0.00289	CcSEcCtD
Tetrabenazine—Angiopathy—Docetaxel—pancreatic cancer	0.000475	0.00287	CcSEcCtD
Tetrabenazine—Insomnia—Gemcitabine—pancreatic cancer	0.000474	0.00286	CcSEcCtD
Tetrabenazine—Headache—Erlotinib—pancreatic cancer	0.000473	0.00286	CcSEcCtD
Tetrabenazine—Osteoarthritis—Doxorubicin—pancreatic cancer	0.000472	0.00285	CcSEcCtD
Tetrabenazine—Asthenia—Sunitinib—pancreatic cancer	0.000468	0.00283	CcSEcCtD
Tetrabenazine—Decreased appetite—Irinotecan—pancreatic cancer	0.000468	0.00283	CcSEcCtD
Tetrabenazine—Dyspnoea—Gemcitabine—pancreatic cancer	0.000467	0.00282	CcSEcCtD
Tetrabenazine—Orthostatic hypotension—Epirubicin—pancreatic cancer	0.000466	0.00282	CcSEcCtD
Tetrabenazine—Abdominal pain upper—Epirubicin—pancreatic cancer	0.000466	0.00282	CcSEcCtD
Tetrabenazine—Insomnia—Fluorouracil—pancreatic cancer	0.000466	0.00282	CcSEcCtD
Tetrabenazine—Somnolence—Gemcitabine—pancreatic cancer	0.000466	0.00282	CcSEcCtD
Tetrabenazine—Fatigue—Irinotecan—pancreatic cancer	0.000464	0.0028	CcSEcCtD
Tetrabenazine—Breast disorder—Epirubicin—pancreatic cancer	0.000461	0.00279	CcSEcCtD
Tetrabenazine—Constipation—Irinotecan—pancreatic cancer	0.00046	0.00278	CcSEcCtD
Tetrabenazine—Dyspnoea—Fluorouracil—pancreatic cancer	0.000459	0.00278	CcSEcCtD
Tetrabenazine—Mental disorder—Docetaxel—pancreatic cancer	0.000458	0.00277	CcSEcCtD
Tetrabenazine—Somnolence—Fluorouracil—pancreatic cancer	0.000458	0.00277	CcSEcCtD
Tetrabenazine—Decreased appetite—Gemcitabine—pancreatic cancer	0.000455	0.00275	CcSEcCtD
Tetrabenazine—Nausea—Tamoxifen—pancreatic cancer	0.000453	0.00274	CcSEcCtD
Tetrabenazine—Fatigue—Gemcitabine—pancreatic cancer	0.000452	0.00273	CcSEcCtD
Tetrabenazine—Constipation—Gemcitabine—pancreatic cancer	0.000448	0.00271	CcSEcCtD
Tetrabenazine—Nausea—Erlotinib—pancreatic cancer	0.000448	0.00271	CcSEcCtD
Tetrabenazine—Decreased appetite—Fluorouracil—pancreatic cancer	0.000448	0.00271	CcSEcCtD
Tetrabenazine—Diarrhoea—Sunitinib—pancreatic cancer	0.000447	0.0027	CcSEcCtD
Tetrabenazine—Ataxia—Doxorubicin—pancreatic cancer	0.000444	0.00268	CcSEcCtD
Tetrabenazine—Feeling abnormal—Irinotecan—pancreatic cancer	0.000443	0.00268	CcSEcCtD
Tetrabenazine—Dysphagia—Epirubicin—pancreatic cancer	0.000441	0.00267	CcSEcCtD
Tetrabenazine—Dizziness—Sunitinib—pancreatic cancer	0.000432	0.00261	CcSEcCtD
Tetrabenazine—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000432	0.00261	CcSEcCtD
Tetrabenazine—Abdominal pain upper—Doxorubicin—pancreatic cancer	0.000431	0.00261	CcSEcCtD
Tetrabenazine—Orthostatic hypotension—Doxorubicin—pancreatic cancer	0.000431	0.00261	CcSEcCtD
Tetrabenazine—Breast disorder—Doxorubicin—pancreatic cancer	0.000427	0.00258	CcSEcCtD
Tetrabenazine—Body temperature increased—Irinotecan—pancreatic cancer	0.000425	0.00257	CcSEcCtD
Tetrabenazine—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000424	0.00257	CcSEcCtD
Tetrabenazine—Bronchitis—Epirubicin—pancreatic cancer	0.000424	0.00256	CcSEcCtD
Tetrabenazine—Vomiting—Sunitinib—pancreatic cancer	0.000415	0.00251	CcSEcCtD
Tetrabenazine—Body temperature increased—Gemcitabine—pancreatic cancer	0.000414	0.0025	CcSEcCtD
Tetrabenazine—Dysuria—Epirubicin—pancreatic cancer	0.000412	0.00249	CcSEcCtD
Tetrabenazine—Upper respiratory tract infection—Epirubicin—pancreatic cancer	0.00041	0.00248	CcSEcCtD
Tetrabenazine—CBR1—Arachidonic acid metabolism—PTGS2—pancreatic cancer	0.00041	0.0237	CbGpPWpGaD
Tetrabenazine—Headache—Sunitinib—pancreatic cancer	0.000409	0.00247	CcSEcCtD
Tetrabenazine—Dysphagia—Doxorubicin—pancreatic cancer	0.000408	0.00247	CcSEcCtD
Tetrabenazine—Leukopenia—Docetaxel—pancreatic cancer	0.000408	0.00246	CcSEcCtD
Tetrabenazine—Body temperature increased—Fluorouracil—pancreatic cancer	0.000407	0.00246	CcSEcCtD
Tetrabenazine—SLC18A2—SLC-mediated transmembrane transport—SLC29A1—pancreatic cancer	0.000403	0.0234	CbGpPWpGaD
Tetrabenazine—CBR1—NRF2 pathway—HSPA1A—pancreatic cancer	0.000399	0.0231	CbGpPWpGaD
Tetrabenazine—Drowsiness—Epirubicin—pancreatic cancer	0.000393	0.00238	CcSEcCtD
Tetrabenazine—Bronchitis—Doxorubicin—pancreatic cancer	0.000392	0.00237	CcSEcCtD
Tetrabenazine—Nausea—Sunitinib—pancreatic cancer	0.000388	0.00234	CcSEcCtD
Tetrabenazine—Asthenia—Irinotecan—pancreatic cancer	0.000386	0.00233	CcSEcCtD
Tetrabenazine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000385	0.00233	CcSEcCtD
Tetrabenazine—Dysuria—Doxorubicin—pancreatic cancer	0.000382	0.00231	CcSEcCtD
Tetrabenazine—Dry mouth—Docetaxel—pancreatic cancer	0.000379	0.00229	CcSEcCtD
Tetrabenazine—Upper respiratory tract infection—Doxorubicin—pancreatic cancer	0.000379	0.00229	CcSEcCtD
Tetrabenazine—Sweating—Epirubicin—pancreatic cancer	0.000377	0.00228	CcSEcCtD
Tetrabenazine—Asthenia—Gemcitabine—pancreatic cancer	0.000376	0.00227	CcSEcCtD
Tetrabenazine—Confusional state—Docetaxel—pancreatic cancer	0.000375	0.00227	CcSEcCtD
Tetrabenazine—Diarrhoea—Irinotecan—pancreatic cancer	0.000368	0.00222	CcSEcCtD
Tetrabenazine—Nervous system disorder—Docetaxel—pancreatic cancer	0.000365	0.0022	CcSEcCtD
Tetrabenazine—Drowsiness—Doxorubicin—pancreatic cancer	0.000364	0.0022	CcSEcCtD
Tetrabenazine—Skin disorder—Docetaxel—pancreatic cancer	0.000361	0.00218	CcSEcCtD
Tetrabenazine—Bradycardia—Epirubicin—pancreatic cancer	0.000359	0.00217	CcSEcCtD
Tetrabenazine—Diarrhoea—Gemcitabine—pancreatic cancer	0.000358	0.00217	CcSEcCtD
Tetrabenazine—Dizziness—Irinotecan—pancreatic cancer	0.000356	0.00215	CcSEcCtD
Tetrabenazine—Diarrhoea—Fluorouracil—pancreatic cancer	0.000352	0.00213	CcSEcCtD
Tetrabenazine—Sweating—Doxorubicin—pancreatic cancer	0.000349	0.00211	CcSEcCtD
Tetrabenazine—Urinary tract disorder—Epirubicin—pancreatic cancer	0.000349	0.00211	CcSEcCtD
Tetrabenazine—Hypotension—Docetaxel—pancreatic cancer	0.000347	0.0021	CcSEcCtD
Tetrabenazine—Urethral disorder—Epirubicin—pancreatic cancer	0.000346	0.00209	CcSEcCtD
Tetrabenazine—Vomiting—Irinotecan—pancreatic cancer	0.000342	0.00207	CcSEcCtD
Tetrabenazine—Dizziness—Fluorouracil—pancreatic cancer	0.000341	0.00206	CcSEcCtD
Tetrabenazine—Headache—Irinotecan—pancreatic cancer	0.000337	0.00204	CcSEcCtD
Tetrabenazine—Insomnia—Docetaxel—pancreatic cancer	0.000336	0.00203	CcSEcCtD
Tetrabenazine—SLC18A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A2—pancreatic cancer	0.000335	0.0194	CbGpPWpGaD
Tetrabenazine—Vomiting—Gemcitabine—pancreatic cancer	0.000333	0.00201	CcSEcCtD
Tetrabenazine—Bradycardia—Doxorubicin—pancreatic cancer	0.000332	0.00201	CcSEcCtD
Tetrabenazine—Dyspnoea—Docetaxel—pancreatic cancer	0.000331	0.002	CcSEcCtD
Tetrabenazine—Somnolence—Docetaxel—pancreatic cancer	0.000331	0.002	CcSEcCtD
Tetrabenazine—Eye disorder—Epirubicin—pancreatic cancer	0.00033	0.00199	CcSEcCtD
Tetrabenazine—Headache—Gemcitabine—pancreatic cancer	0.000328	0.00198	CcSEcCtD
Tetrabenazine—Cardiac disorder—Epirubicin—pancreatic cancer	0.000328	0.00198	CcSEcCtD
Tetrabenazine—Vomiting—Fluorouracil—pancreatic cancer	0.000328	0.00198	CcSEcCtD
Tetrabenazine—Decreased appetite—Docetaxel—pancreatic cancer	0.000323	0.00195	CcSEcCtD
Tetrabenazine—Headache—Fluorouracil—pancreatic cancer	0.000323	0.00195	CcSEcCtD
Tetrabenazine—Urinary tract disorder—Doxorubicin—pancreatic cancer	0.000323	0.00195	CcSEcCtD
Tetrabenazine—Fatigue—Docetaxel—pancreatic cancer	0.000321	0.00194	CcSEcCtD
Tetrabenazine—Angiopathy—Epirubicin—pancreatic cancer	0.00032	0.00194	CcSEcCtD
Tetrabenazine—Urethral disorder—Doxorubicin—pancreatic cancer	0.00032	0.00194	CcSEcCtD
Tetrabenazine—Nausea—Irinotecan—pancreatic cancer	0.000319	0.00193	CcSEcCtD
Tetrabenazine—Constipation—Docetaxel—pancreatic cancer	0.000318	0.00192	CcSEcCtD
Tetrabenazine—Nausea—Gemcitabine—pancreatic cancer	0.000311	0.00188	CcSEcCtD
Tetrabenazine—Mental disorder—Epirubicin—pancreatic cancer	0.000309	0.00187	CcSEcCtD
Tetrabenazine—Feeling abnormal—Docetaxel—pancreatic cancer	0.000306	0.00185	CcSEcCtD
Tetrabenazine—Nausea—Fluorouracil—pancreatic cancer	0.000306	0.00185	CcSEcCtD
Tetrabenazine—Eye disorder—Doxorubicin—pancreatic cancer	0.000305	0.00184	CcSEcCtD
Tetrabenazine—Cardiac disorder—Doxorubicin—pancreatic cancer	0.000303	0.00183	CcSEcCtD
Tetrabenazine—Tension—Epirubicin—pancreatic cancer	0.000302	0.00182	CcSEcCtD
Tetrabenazine—Nervousness—Epirubicin—pancreatic cancer	0.000298	0.0018	CcSEcCtD
Tetrabenazine—Angiopathy—Doxorubicin—pancreatic cancer	0.000296	0.00179	CcSEcCtD
Tetrabenazine—Body temperature increased—Docetaxel—pancreatic cancer	0.000294	0.00178	CcSEcCtD
Tetrabenazine—Mental disorder—Doxorubicin—pancreatic cancer	0.000286	0.00173	CcSEcCtD
Tetrabenazine—Agitation—Epirubicin—pancreatic cancer	0.000282	0.00171	CcSEcCtD
Tetrabenazine—Tension—Doxorubicin—pancreatic cancer	0.000279	0.00169	CcSEcCtD
Tetrabenazine—Nervousness—Doxorubicin—pancreatic cancer	0.000276	0.00167	CcSEcCtD
Tetrabenazine—Leukopenia—Epirubicin—pancreatic cancer	0.000275	0.00166	CcSEcCtD
Tetrabenazine—Asthenia—Docetaxel—pancreatic cancer	0.000267	0.00161	CcSEcCtD
Tetrabenazine—Agitation—Doxorubicin—pancreatic cancer	0.000261	0.00158	CcSEcCtD
Tetrabenazine—Anxiety—Epirubicin—pancreatic cancer	0.000261	0.00158	CcSEcCtD
Tetrabenazine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.00026	0.00157	CcSEcCtD
Tetrabenazine—Dry mouth—Epirubicin—pancreatic cancer	0.000256	0.00155	CcSEcCtD
Tetrabenazine—Leukopenia—Doxorubicin—pancreatic cancer	0.000254	0.00154	CcSEcCtD
Tetrabenazine—Diarrhoea—Docetaxel—pancreatic cancer	0.000254	0.00154	CcSEcCtD
Tetrabenazine—Confusional state—Epirubicin—pancreatic cancer	0.000253	0.00153	CcSEcCtD
Tetrabenazine—SLC18A2—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	0.000251	0.0146	CbGpPWpGaD
Tetrabenazine—Nervous system disorder—Epirubicin—pancreatic cancer	0.000246	0.00149	CcSEcCtD
Tetrabenazine—Dizziness—Docetaxel—pancreatic cancer	0.000246	0.00149	CcSEcCtD
Tetrabenazine—Skin disorder—Epirubicin—pancreatic cancer	0.000244	0.00147	CcSEcCtD
Tetrabenazine—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000242	0.00147	CcSEcCtD
Tetrabenazine—Anxiety—Doxorubicin—pancreatic cancer	0.000241	0.00146	CcSEcCtD
Tetrabenazine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.00024	0.00145	CcSEcCtD
Tetrabenazine—Dry mouth—Doxorubicin—pancreatic cancer	0.000237	0.00143	CcSEcCtD
Tetrabenazine—Vomiting—Docetaxel—pancreatic cancer	0.000236	0.00143	CcSEcCtD
Tetrabenazine—Hypotension—Epirubicin—pancreatic cancer	0.000234	0.00142	CcSEcCtD
Tetrabenazine—Confusional state—Doxorubicin—pancreatic cancer	0.000234	0.00141	CcSEcCtD
Tetrabenazine—Headache—Docetaxel—pancreatic cancer	0.000233	0.00141	CcSEcCtD
Tetrabenazine—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000228	0.00138	CcSEcCtD
Tetrabenazine—Insomnia—Epirubicin—pancreatic cancer	0.000227	0.00137	CcSEcCtD
Tetrabenazine—Skin disorder—Doxorubicin—pancreatic cancer	0.000225	0.00136	CcSEcCtD
Tetrabenazine—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000224	0.00136	CcSEcCtD
Tetrabenazine—SLC18A2—Dopaminergic Neurogenesis—STAT3—pancreatic cancer	0.000224	0.013	CbGpPWpGaD
Tetrabenazine—Dyspnoea—Epirubicin—pancreatic cancer	0.000224	0.00135	CcSEcCtD
Tetrabenazine—Somnolence—Epirubicin—pancreatic cancer	0.000223	0.00135	CcSEcCtD
Tetrabenazine—Nausea—Docetaxel—pancreatic cancer	0.000221	0.00133	CcSEcCtD
Tetrabenazine—Decreased appetite—Epirubicin—pancreatic cancer	0.000218	0.00132	CcSEcCtD
Tetrabenazine—Hypotension—Doxorubicin—pancreatic cancer	0.000217	0.00131	CcSEcCtD
Tetrabenazine—Fatigue—Epirubicin—pancreatic cancer	0.000216	0.00131	CcSEcCtD
Tetrabenazine—Constipation—Epirubicin—pancreatic cancer	0.000214	0.0013	CcSEcCtD
Tetrabenazine—Insomnia—Doxorubicin—pancreatic cancer	0.00021	0.00127	CcSEcCtD
Tetrabenazine—SLC18A2—Dopaminergic Neurogenesis—TGFB1—pancreatic cancer	0.000207	0.012	CbGpPWpGaD
Tetrabenazine—Dyspnoea—Doxorubicin—pancreatic cancer	0.000207	0.00125	CcSEcCtD
Tetrabenazine—Feeling abnormal—Epirubicin—pancreatic cancer	0.000207	0.00125	CcSEcCtD
Tetrabenazine—Somnolence—Doxorubicin—pancreatic cancer	0.000206	0.00125	CcSEcCtD
Tetrabenazine—SLC18A2—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	0.000205	0.0119	CbGpPWpGaD
Tetrabenazine—Decreased appetite—Doxorubicin—pancreatic cancer	0.000202	0.00122	CcSEcCtD
Tetrabenazine—Fatigue—Doxorubicin—pancreatic cancer	0.0002	0.00121	CcSEcCtD
Tetrabenazine—Constipation—Doxorubicin—pancreatic cancer	0.000198	0.0012	CcSEcCtD
Tetrabenazine—Body temperature increased—Epirubicin—pancreatic cancer	0.000198	0.0012	CcSEcCtD
Tetrabenazine—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000191	0.00116	CcSEcCtD
Tetrabenazine—Body temperature increased—Doxorubicin—pancreatic cancer	0.000183	0.00111	CcSEcCtD
Tetrabenazine—Asthenia—Epirubicin—pancreatic cancer	0.00018	0.00109	CcSEcCtD
Tetrabenazine—Diarrhoea—Epirubicin—pancreatic cancer	0.000172	0.00104	CcSEcCtD
Tetrabenazine—Asthenia—Doxorubicin—pancreatic cancer	0.000166	0.00101	CcSEcCtD
Tetrabenazine—Dizziness—Epirubicin—pancreatic cancer	0.000166	0.001	CcSEcCtD
Tetrabenazine—Vomiting—Epirubicin—pancreatic cancer	0.000159	0.000964	CcSEcCtD
Tetrabenazine—Diarrhoea—Doxorubicin—pancreatic cancer	0.000159	0.00096	CcSEcCtD
Tetrabenazine—Headache—Epirubicin—pancreatic cancer	0.000157	0.00095	CcSEcCtD
Tetrabenazine—Dizziness—Doxorubicin—pancreatic cancer	0.000153	0.000927	CcSEcCtD
Tetrabenazine—SLC18A2—SLC-mediated transmembrane transport—SLC2A2—pancreatic cancer	0.000152	0.00883	CbGpPWpGaD
Tetrabenazine—Nausea—Epirubicin—pancreatic cancer	0.000149	0.0009	CcSEcCtD
Tetrabenazine—Vomiting—Doxorubicin—pancreatic cancer	0.000148	0.000892	CcSEcCtD
Tetrabenazine—Headache—Doxorubicin—pancreatic cancer	0.000145	0.000879	CcSEcCtD
Tetrabenazine—Nausea—Doxorubicin—pancreatic cancer	0.000138	0.000833	CcSEcCtD
Tetrabenazine—DRD2—GPCRs, Class A Rhodopsin-like—PRLHR—pancreatic cancer	0.000137	0.00793	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—PRSS1—pancreatic cancer	0.000137	0.00791	CbGpPWpGaD
Tetrabenazine—CBR1—NRF2 pathway—TGFB1—pancreatic cancer	0.000126	0.00728	CbGpPWpGaD
Tetrabenazine—DRD2—G alpha (i) signalling events—SSTR3—pancreatic cancer	0.000125	0.00726	CbGpPWpGaD
Tetrabenazine—DRD2—G alpha (i) signalling events—SSTR1—pancreatic cancer	0.00012	0.00696	CbGpPWpGaD
Tetrabenazine—CYP2D6—Melatonin metabolism and effects—APOE—pancreatic cancer	0.00012	0.00696	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—ARG2—pancreatic cancer	0.000118	0.00686	CbGpPWpGaD
Tetrabenazine—DRD2—G alpha (i) signalling events—PPY—pancreatic cancer	0.000118	0.00683	CbGpPWpGaD
Tetrabenazine—DRD2—Class A/1 (Rhodopsin-like receptors)—PRLHR—pancreatic cancer	0.000117	0.00679	CbGpPWpGaD
Tetrabenazine—DRD2—GPCRs, Class A Rhodopsin-like—SSTR3—pancreatic cancer	0.000116	0.00674	CbGpPWpGaD
Tetrabenazine—DRD2—G alpha (i) signalling events—SSTR2—pancreatic cancer	0.000116	0.0067	CbGpPWpGaD
Tetrabenazine—DRD2—GPCRs, Class A Rhodopsin-like—SSTR1—pancreatic cancer	0.000112	0.00646	CbGpPWpGaD
Tetrabenazine—DRD2—GPCRs, Class A Rhodopsin-like—SSTR2—pancreatic cancer	0.000107	0.00622	CbGpPWpGaD
Tetrabenazine—DRD2—GPCRs, Class A Rhodopsin-like—CCKBR—pancreatic cancer	0.000104	0.00601	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—TYMP—pancreatic cancer	0.000104	0.006	CbGpPWpGaD
Tetrabenazine—DRD2—Class A/1 (Rhodopsin-like receptors)—SSTR3—pancreatic cancer	9.97e-05	0.00578	CbGpPWpGaD
Tetrabenazine—DRD2—Circadian rythm related genes—AHR—pancreatic cancer	9.85e-05	0.00571	CbGpPWpGaD
Tetrabenazine—DRD2—Class A/1 (Rhodopsin-like receptors)—SSTR1—pancreatic cancer	9.56e-05	0.00554	CbGpPWpGaD
Tetrabenazine—DRD2—Class A/1 (Rhodopsin-like receptors)—PPY—pancreatic cancer	9.38e-05	0.00543	CbGpPWpGaD
Tetrabenazine—DRD2—Class A/1 (Rhodopsin-like receptors)—SSTR2—pancreatic cancer	9.2e-05	0.00533	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR ligand binding—PRLHR—pancreatic cancer	8.93e-05	0.00517	CbGpPWpGaD
Tetrabenazine—DRD2—Class A/1 (Rhodopsin-like receptors)—CCKBR—pancreatic cancer	8.89e-05	0.00515	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	8.54e-05	0.00495	CbGpPWpGaD
Tetrabenazine—DRD2—G alpha (i) signalling events—CNR2—pancreatic cancer	8.47e-05	0.00491	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—GLP1R—pancreatic cancer	8.34e-05	0.00483	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—DPYD—pancreatic cancer	8.21e-05	0.00475	CbGpPWpGaD
Tetrabenazine—DRD2—GPCRs, Class A Rhodopsin-like—CNR2—pancreatic cancer	7.86e-05	0.00455	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—SLC2A2—pancreatic cancer	7.79e-05	0.00451	CbGpPWpGaD
Tetrabenazine—SLC18A2—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	7.74e-05	0.00449	CbGpPWpGaD
Tetrabenazine—DRD2—GPCRs, Class A Rhodopsin-like—CCKAR—pancreatic cancer	7.73e-05	0.00448	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	7.71e-05	0.00447	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR ligand binding—SSTR3—pancreatic cancer	7.59e-05	0.0044	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	7.44e-05	0.00431	CbGpPWpGaD
Tetrabenazine—DRD2—Circadian rythm related genes—EZH2—pancreatic cancer	7.43e-05	0.00431	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR ligand binding—SSTR1—pancreatic cancer	7.28e-05	0.00422	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR ligand binding—PPY—pancreatic cancer	7.14e-05	0.00414	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR ligand binding—SSTR2—pancreatic cancer	7.01e-05	0.00406	CbGpPWpGaD
Tetrabenazine—DRD2—Class A/1 (Rhodopsin-like receptors)—CCK—pancreatic cancer	6.91e-05	0.004	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	6.78e-05	0.00393	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR ligand binding—CCKBR—pancreatic cancer	6.77e-05	0.00392	CbGpPWpGaD
Tetrabenazine—DRD2—Class A/1 (Rhodopsin-like receptors)—CNR2—pancreatic cancer	6.74e-05	0.0039	CbGpPWpGaD
Tetrabenazine—DRD2—Class A/1 (Rhodopsin-like receptors)—CCKAR—pancreatic cancer	6.63e-05	0.00384	CbGpPWpGaD
Tetrabenazine—DRD2—G alpha (i) signalling events—SST—pancreatic cancer	6.59e-05	0.00382	CbGpPWpGaD
Tetrabenazine—DRD2—G alpha (i) signalling events—CNR1—pancreatic cancer	6.08e-05	0.00352	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—CD44—pancreatic cancer	6.03e-05	0.00349	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	5.91e-05	0.00342	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	5.85e-05	0.00339	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—GCG—pancreatic cancer	5.78e-05	0.00335	CbGpPWpGaD
Tetrabenazine—DRD2—GPCRs, Class A Rhodopsin-like—CNR1—pancreatic cancer	5.64e-05	0.00327	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR ligand binding—SCT—pancreatic cancer	5.52e-05	0.0032	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—STK11—pancreatic cancer	5.44e-05	0.00315	CbGpPWpGaD
Tetrabenazine—DRD2—Circadian rythm related genes—TYMS—pancreatic cancer	5.38e-05	0.00312	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR ligand binding—CCK—pancreatic cancer	5.26e-05	0.00305	CbGpPWpGaD
Tetrabenazine—DRD2—Class A/1 (Rhodopsin-like receptors)—SST—pancreatic cancer	5.24e-05	0.00303	CbGpPWpGaD
Tetrabenazine—DRD2—GPCRs, Class A Rhodopsin-like—AGTR1—pancreatic cancer	5.2e-05	0.00301	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR ligand binding—CNR2—pancreatic cancer	5.13e-05	0.00297	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR ligand binding—GLP1R—pancreatic cancer	5.13e-05	0.00297	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	5.1e-05	0.00296	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR ligand binding—CCKAR—pancreatic cancer	5.05e-05	0.00292	CbGpPWpGaD
Tetrabenazine—DRD2—Class A/1 (Rhodopsin-like receptors)—CNR1—pancreatic cancer	4.83e-05	0.0028	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—TYMS—pancreatic cancer	4.68e-05	0.00271	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR ligand binding—SHH—pancreatic cancer	4.6e-05	0.00266	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—PRLHR—pancreatic cancer	4.58e-05	0.00265	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR ligand binding—IAPP—pancreatic cancer	4.54e-05	0.00263	CbGpPWpGaD
Tetrabenazine—DRD2—Class A/1 (Rhodopsin-like receptors)—AGTR1—pancreatic cancer	4.45e-05	0.00258	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR ligand binding—PTHLH—pancreatic cancer	4.36e-05	0.00253	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR ligand binding—PTCH1—pancreatic cancer	4.36e-05	0.00253	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—SSTR3—pancreatic cancer	4.29e-05	0.00249	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—GDI2—pancreatic cancer	4.2e-05	0.00243	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—GDI1—pancreatic cancer	4.2e-05	0.00243	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—SSTR1—pancreatic cancer	4.11e-05	0.00238	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—PPY—pancreatic cancer	4.03e-05	0.00234	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR ligand binding—SST—pancreatic cancer	3.99e-05	0.00231	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—SSTR2—pancreatic cancer	3.96e-05	0.00229	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—SSTR3—pancreatic cancer	3.9e-05	0.00226	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—CCKBR—pancreatic cancer	3.82e-05	0.00222	CbGpPWpGaD
Tetrabenazine—DRD2—Circadian rythm related genes—PPARG—pancreatic cancer	3.81e-05	0.00221	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—APOE—pancreatic cancer	3.8e-05	0.0022	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—SSTR1—pancreatic cancer	3.74e-05	0.00216	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR ligand binding—CNR1—pancreatic cancer	3.68e-05	0.00213	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—PPY—pancreatic cancer	3.66e-05	0.00212	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	3.6e-05	0.00209	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—SSTR2—pancreatic cancer	3.6e-05	0.00208	CbGpPWpGaD
Tetrabenazine—SLC18A2—Transmission across Chemical Synapses—HRAS—pancreatic cancer	3.58e-05	0.00207	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR ligand binding—GCG—pancreatic cancer	3.56e-05	0.00206	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—CCKBR—pancreatic cancer	3.47e-05	0.00201	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—PIK3CG—pancreatic cancer	3.43e-05	0.00199	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR ligand binding—AGTR1—pancreatic cancer	3.39e-05	0.00196	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—PPARG—pancreatic cancer	3.31e-05	0.00192	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—GAST—pancreatic cancer	3.29e-05	0.00191	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—SCT—pancreatic cancer	3.12e-05	0.00181	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—PIK3CD—pancreatic cancer	3.02e-05	0.00175	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—GAST—pancreatic cancer	2.99e-05	0.00173	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—CCK—pancreatic cancer	2.97e-05	0.00172	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—CNR2—pancreatic cancer	2.9e-05	0.00168	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—GLP1R—pancreatic cancer	2.9e-05	0.00168	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—CCKAR—pancreatic cancer	2.85e-05	0.00165	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—SCT—pancreatic cancer	2.83e-05	0.00164	CbGpPWpGaD
Tetrabenazine—SLC18A2—Neuronal System—HRAS—pancreatic cancer	2.74e-05	0.00159	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—PRLHR—pancreatic cancer	2.71e-05	0.00157	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—CCK—pancreatic cancer	2.7e-05	0.00156	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—CNR2—pancreatic cancer	2.63e-05	0.00152	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—GLP1R—pancreatic cancer	2.63e-05	0.00152	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—PIK3CB—pancreatic cancer	2.63e-05	0.00152	CbGpPWpGaD
Tetrabenazine—DRD2—Circadian rythm related genes—PTEN—pancreatic cancer	2.62e-05	0.00151	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—PTGS2—pancreatic cancer	2.61e-05	0.00151	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—CCKAR—pancreatic cancer	2.59e-05	0.0015	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—IAPP—pancreatic cancer	2.57e-05	0.00149	CbGpPWpGaD
Tetrabenazine—DRD2—G alpha (i) signalling events—CXCL8—pancreatic cancer	2.57e-05	0.00149	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—ACVR1B—pancreatic cancer	2.55e-05	0.00147	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—ZNRF3—pancreatic cancer	2.55e-05	0.00147	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—PTHLH—pancreatic cancer	2.46e-05	0.00143	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—SHH—pancreatic cancer	2.36e-05	0.00137	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—IAPP—pancreatic cancer	2.33e-05	0.00135	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—SSTR3—pancreatic cancer	2.3e-05	0.00133	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—DTX1—pancreatic cancer	2.3e-05	0.00133	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—PTEN—pancreatic cancer	2.27e-05	0.00132	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—SST—pancreatic cancer	2.25e-05	0.00131	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—PTHLH—pancreatic cancer	2.24e-05	0.0013	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—PTCH1—pancreatic cancer	2.24e-05	0.0013	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—SSTR1—pancreatic cancer	2.21e-05	0.00128	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—PPY—pancreatic cancer	2.16e-05	0.00125	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—SSTR2—pancreatic cancer	2.12e-05	0.00123	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—CNR1—pancreatic cancer	2.08e-05	0.0012	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—CCKBR—pancreatic cancer	2.05e-05	0.00119	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—SST—pancreatic cancer	2.05e-05	0.00119	CbGpPWpGaD
Tetrabenazine—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatic cancer	2.04e-05	0.00118	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—GCG—pancreatic cancer	2.01e-05	0.00116	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—DTX4—pancreatic cancer	1.93e-05	0.00112	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—GLI1—pancreatic cancer	1.93e-05	0.00112	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—AGTR1—pancreatic cancer	1.92e-05	0.00111	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—CNR1—pancreatic cancer	1.89e-05	0.00109	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—PPP2R5B—pancreatic cancer	1.88e-05	0.00109	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—NRP1—pancreatic cancer	1.88e-05	0.00109	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—GCG—pancreatic cancer	1.82e-05	0.00106	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—HEY2—pancreatic cancer	1.81e-05	0.00105	CbGpPWpGaD
Tetrabenazine—DRD2—Circadian rythm related genes—TP53—pancreatic cancer	1.78e-05	0.00103	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—PRSS1—pancreatic cancer	1.78e-05	0.00103	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—GAST—pancreatic cancer	1.76e-05	0.00102	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—AGTR1—pancreatic cancer	1.74e-05	0.00101	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—SCT—pancreatic cancer	1.67e-05	0.000969	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—HEY1—pancreatic cancer	1.67e-05	0.000969	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—PIK3CA—pancreatic cancer	1.6e-05	0.000929	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—CCK—pancreatic cancer	1.6e-05	0.000924	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—CNR2—pancreatic cancer	1.55e-05	0.000901	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—GLP1R—pancreatic cancer	1.55e-05	0.000901	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR ligand binding—CXCL8—pancreatic cancer	1.55e-05	0.0009	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—ARG2—pancreatic cancer	1.54e-05	0.000892	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—CCKAR—pancreatic cancer	1.53e-05	0.000886	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—JAG2—pancreatic cancer	1.48e-05	0.000859	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—MEN1—pancreatic cancer	1.46e-05	0.000847	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—SHH—pancreatic cancer	1.39e-05	0.000808	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—NOTCH4—pancreatic cancer	1.39e-05	0.000803	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—IAPP—pancreatic cancer	1.38e-05	0.000798	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—TYMP—pancreatic cancer	1.35e-05	0.000779	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—PTHLH—pancreatic cancer	1.32e-05	0.000766	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—PTCH1—pancreatic cancer	1.32e-05	0.000766	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—AKT1—pancreatic cancer	1.31e-05	0.000759	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—SST—pancreatic cancer	1.21e-05	0.0007	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—PIK3CG—pancreatic cancer	1.19e-05	0.000691	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—JAG1—pancreatic cancer	1.18e-05	0.000685	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—NOTCH3—pancreatic cancer	1.18e-05	0.000683	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—CNR1—pancreatic cancer	1.12e-05	0.000646	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—GLP1R—pancreatic cancer	1.08e-05	0.000628	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—PIK3CG—pancreatic cancer	1.08e-05	0.000627	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—GCG—pancreatic cancer	1.08e-05	0.000624	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—DPYD—pancreatic cancer	1.07e-05	0.000618	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—PIK3CD—pancreatic cancer	1.05e-05	0.000607	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—AGTR1—pancreatic cancer	1.03e-05	0.000596	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—STK11—pancreatic cancer	1.01e-05	0.000587	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—SLC2A2—pancreatic cancer	1.01e-05	0.000587	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—PIK3CD—pancreatic cancer	9.52e-06	0.000551	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—PIK3CB—pancreatic cancer	9.14e-06	0.000529	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—SMAD4—pancreatic cancer	8.88e-06	0.000514	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—CXCL8—pancreatic cancer	8.78e-06	0.000509	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—HES1—pancreatic cancer	8.67e-06	0.000502	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—PIK3CB—pancreatic cancer	8.3e-06	0.000481	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—CXCL8—pancreatic cancer	7.98e-06	0.000462	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—CD44—pancreatic cancer	7.84e-06	0.000454	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—TERT—pancreatic cancer	7.59e-06	0.00044	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—GCG—pancreatic cancer	7.52e-06	0.000436	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—HIF1A—pancreatic cancer	7.26e-06	0.000421	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—TSC2—pancreatic cancer	7.24e-06	0.00042	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—APOE—pancreatic cancer	7.09e-06	0.000411	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—STK11—pancreatic cancer	7.07e-06	0.000409	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—KDR—pancreatic cancer	6.95e-06	0.000402	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—NFKBIA—pancreatic cancer	6.61e-06	0.000383	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—NOTCH1—pancreatic cancer	6.54e-06	0.000379	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—PIK3CG—pancreatic cancer	6.4e-06	0.000371	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—NRAS—pancreatic cancer	6.4e-06	0.000371	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—EGF—pancreatic cancer	6.32e-06	0.000366	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—TYMS—pancreatic cancer	6.08e-06	0.000352	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—EGFR—pancreatic cancer	5.83e-06	0.000338	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—PIK3CD—pancreatic cancer	5.62e-06	0.000326	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—PIK3CA—pancreatic cancer	5.57e-06	0.000323	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—KRAS—pancreatic cancer	5.51e-06	0.000319	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—PIK3CA—pancreatic cancer	5.06e-06	0.000293	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—APOE—pancreatic cancer	4.95e-06	0.000286	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—PIK3CB—pancreatic cancer	4.9e-06	0.000284	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—CXCL8—pancreatic cancer	4.71e-06	0.000273	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—HRAS—pancreatic cancer	4.68e-06	0.000271	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—AKT1—pancreatic cancer	4.55e-06	0.000264	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—CASP3—pancreatic cancer	4.51e-06	0.000261	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—PIK3CG—pancreatic cancer	4.46e-06	0.000259	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—CCND1—pancreatic cancer	4.39e-06	0.000254	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—CTNNB1—pancreatic cancer	4.35e-06	0.000252	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—PPARG—pancreatic cancer	4.31e-06	0.00025	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—MMP9—pancreatic cancer	4.26e-06	0.000247	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—PTEN—pancreatic cancer	4.24e-06	0.000245	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—AKT1—pancreatic cancer	4.13e-06	0.000239	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—SRC—pancreatic cancer	3.93e-06	0.000228	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—PIK3CD—pancreatic cancer	3.92e-06	0.000227	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—VEGFA—pancreatic cancer	3.83e-06	0.000222	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—STAT3—pancreatic cancer	3.79e-06	0.000219	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—NRAS—pancreatic cancer	3.78e-06	0.000219	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—MYC—pancreatic cancer	3.52e-06	0.000204	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—TGFB1—pancreatic cancer	3.51e-06	0.000203	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—EGFR—pancreatic cancer	3.44e-06	0.000199	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—PIK3CB—pancreatic cancer	3.42e-06	0.000198	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—PTGS2—pancreatic cancer	3.39e-06	0.000196	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—KRAS—pancreatic cancer	3.25e-06	0.000188	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—PIK3CA—pancreatic cancer	2.99e-06	0.000173	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—PTEN—pancreatic cancer	2.96e-06	0.000171	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—TP53—pancreatic cancer	2.89e-06	0.000167	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—HRAS—pancreatic cancer	2.77e-06	0.00016	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—AKT1—pancreatic cancer	2.44e-06	0.000141	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—PIK3CA—pancreatic cancer	2.08e-06	0.000121	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—AKT1—pancreatic cancer	1.7e-06	9.87e-05	CbGpPWpGaD
